Stephen C. Glover
2022
In 2022, Stephen C. Glover earned a total compensation of $1.5M as Co-Founder, Chief Executive Officer President and Chairman at ZyVersa Therapeutics.
Compensation breakdown
| Option Awards | $1,027,948 |
|---|---|
| Salary | $450,500 |
| Total | $1,478,448 |
Glover received $1M in option awards, accounting for 70% of the total pay in 2022.
Glover also received $450.5K in salary.
Rankings
In 2022, Stephen C. Glover's compensation ranked 2,238th out of 5,616 executives tracked by ExecPay. In other words, Glover earned more than 60.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,238 out of 5,616 | 60th |
Division Manufacturing | 1,210 out of 3,048 | 60th |
Major group Chemicals And Allied Products | 530 out of 1,375 | 62nd |
Industry group Drugs | 486 out of 1,276 | 62nd |
Industry Pharmaceutical Preparations | 352 out of 924 | 62nd |
Source: SEC filing on September 9, 2024.
Glover's colleagues
We found two more compensation records of executives who worked with Stephen C. Glover at ZyVersa Therapeutics in 2022.